Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioma 1 Communication Disorders 1

Interventions

Temozolomide 47 Bevacizumab 41 Radiotherapy 17 Magnetic Resonance Spectroscopy 14 Irinotecan 11 Nivolumab 8 Everolimus 7 Radiation 6 poly ICLC 5 X-Rays 5 Phantoms, Imaging 5 Carboplatin 5 pembrolizumab 4 fluorodopa F 18 4 Specimen Handling 4 Nuclear Medicine Department, Hospital 4 Granulocyte-Macrophage Colony-Stimulating Factor 4 Erlotinib Hydrochloride 4 Carmustine 4 ribociclib 3 palbociclib 3 ivosidenib 3 antineoplaston A10 3 Vorinostat 3 Radiotherapy, Intensity-Modulated 3 Radiosurgery 3 Modafinil 3 Lomustine 3 Biopsy 3 veliparib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Glioma × Speech Therapy × Clear all

NCT05189366 2026-04-14

SOPHNEURO

Institut Cancerologie de l'Ouest

Phase NA Terminated

13 enrolled 8 charts

Communication Disorders, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡